Liquidia Corp. (LQDA)
27.38
-0.64
(-2.28%)
USD |
NASDAQ |
Oct 09, 16:00
28.20
+0.82
(+2.99%)
Pre-Market: 20:00
Liquidia Free Cash Flow (Quarterly) : 69.01M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.01M |
| March 31, 2026 | 50.16M |
| December 31, 2025 | 42.21M |
| September 30, 2025 | -10.68M |
| June 30, 2025 | -40.54M |
| March 31, 2025 | -31.01M |
| December 31, 2024 | -22.10M |
| September 30, 2024 | -26.83M |
| June 30, 2024 | -23.95M |
| March 31, 2024 | -25.49M |
| December 31, 2023 | -16.19M |
| September 30, 2023 | -12.04M |
| June 30, 2023 | -5.807M |
| March 31, 2023 | -8.823M |
| December 31, 2022 | -5.094M |
| September 30, 2022 | -5.868M |
| June 30, 2022 | -8.436M |
| March 31, 2022 | -9.782M |
| December 31, 2021 | -7.579M |
| Date | Value |
|---|---|
| September 30, 2021 | -5.830M |
| June 30, 2021 | -8.295M |
| March 31, 2021 | -12.44M |
| December 31, 2020 | -14.13M |
| September 30, 2020 | -12.63M |
| June 30, 2020 | -13.52M |
| March 31, 2020 | -14.62M |
| December 31, 2019 | -14.19M |
| September 30, 2019 | -12.59M |
| June 30, 2019 | -13.00M |
| March 31, 2019 | -10.35M |
| December 31, 2018 | -8.430M |
| September 30, 2018 | -6.420M |
| June 30, 2018 | -7.594M |
| March 31, 2018 | -10.26M |
| December 31, 2017 | -5.956M |
| September 30, 2017 | -6.292M |
| June 30, 2017 | -5.493M |
| March 31, 2017 | -9.093M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Harmony Biosciences Holdings, Inc. | 92.43M |
| Johnson & Johnson | 7.295B |
| United Therapeutics Corp. | 202.20M |
| Amneal Pharmaceuticals, Inc. | -143.99M |
| Pfizer Inc. | 302.00M |